Browse > Article

Efficient Gene Delivery into Hematopoietic Stem Cells by Intra-Bone Marrow Injection of Retrovirus  

Lee, Byun-Joo (Graduate School of Life Science and Biotechnology, College of Medicine, CHA Stem Cell Institute, Pochon CHA University)
Lee, Yong-Soo (Graduate School of Life Science and Biotechnology, College of Medicine, CHA Stem Cell Institute, Pochon CHA University)
Kim, Hye-Sun (Graduate School of Life Science and Biotechnology, College of Medicine, CHA Stem Cell Institute, Pochon CHA University)
Kim, Yu-Kyung (Graduate School of Life Science and Biotechnology, College of Medicine, CHA Stem Cell Institute, Pochon CHA University)
Kim, Jae-Hwan (Graduate School of Life Science and Biotechnology, College of Medicine, CHA Stem Cell Institute, Pochon CHA University)
Park, Jin-Ki (Animal Biotechnology Division, National Livestock Research Institute)
Chung, Hak-Jae (Animal Biotechnology Division, National Livestock Research Institute)
Chang, Won-Kyong (Animal Biotechnology Division, National Livestock Research Institute)
Kim, Dong-Ku (Graduate School of Life Science and Biotechnology, College of Medicine, CHA Stem Cell Institute, Pochon CHA University)
Publication Information
Abstract
Efficient gene transfer into hematopoietic stem cells is a great tool for gene therapy of hematopoietic disease. Retrovirus have been extensively used for gene delivery and gene therapy. However, current in vitro gene transfer has some obstacles suck as induction of differentiation loss of self-renewal capacity, and down-regulation of homing efficiency for in vitro hematopoietic stem cells transplantation. To overcome these problems, we developed efficient in vitro retroviral transfer technique by direct intra-bone marrow injection (IBM). We identified effective retrovirus gene transfer in bone marrow hematopoietic cells in vitro. Two weeks after retrovirus transfer via IBM injection, we observed stable EGFP gene expression in bone marrow, lymph node, spleen, and liver cells. In addition, $6.4{\pm}2.7%$ of hematopoietic stem/progenitor cells were expressed EGFP transgene from flow cytometry analysis. Our results demonstrate that in vitro retrovirus gene transfer via IBM injection can provide a viable alternative to current or moo gene transfer approach.
Keywords
Hematopoietic stem cells; In vitro gene transfer; IBM injection; Retrovirus;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ (1995): Murine marrow cells expanded in culture with IL-3, IL-6, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23:461-469
2 Culver KW (1994): The first human gene therapy experiment. Gene therapy-A handbook for physician. Marry Ann Liebert 1:33-40
3 Porada CD, Tran ND, Zhao Y, Anderson WF, Zanjani ED (2000): Neonatal gene therapy: transfer and expression of exogenous genes in neonatal sheep following direct injection of retroviral vectors into the bone marrow space. Exp Hematol 28:642-650   DOI   ScienceOn
4 Pike-OK, Ridder D, Weerkamp F, Baert MR, Thrasher AJ, Wagemaker G, van Dongen JJ, Staal FJ (2006): Gene therapy: Is IL2RG oncogenic in T-cell development?. Nature 21:443-444
5 Kushida T, Inaba M, Hisha H (2001): Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97:3292-3299   DOI   ScienceOn
6 Cavazzana CM, Hacein BS, Saint BG, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000): Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672   DOI
7 Szilvassy SJ, Bass MJ, Zant GV, Grimes B (1999) Organ selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 93:1557-1566
8 Onodera M, Yachie A, Nelson DM, Welchlin H, Morgan RA, Blaese RM (1997): A simple and reliable method for screening retroviral producer clones without selectable markers. Hum Gene Ther 8:1189-1194   DOI   ScienceOn
9 Engel BC, Kohn, DB (2003): Gene therapy for inborn and acquired immune deficiency disorders. Acta Haematol 110:60-70   DOI   ScienceOn
10 Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Walker R (2000): Human gene marker/therapy clinical protocols. Hum Gene Ther 11:919-979   DOI   ScienceOn
11 Hacein BAS, Deist F, Carlier F, Bouneaud C, Hue C, Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis GS, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana CM (2002): Sustained correction of Xlinked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185-1193   DOI   ScienceOn
12 Worsham DN, Schuesler T, Kalle CV, Pan D (2006): In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector. Mol Ther 14:514-524   DOI   ScienceOn
13 Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA (1996): Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian. Nat Med 2:876-882   DOI   ScienceOn
14 Kurre P, Morris J, Horn PA, Harkey MA, Andrews RG, Kiem HP (1998): Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92:1878-1886
15 Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL (2001): Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-1936   DOI
16 Jetmore A, Plett PA, Tong X (2002): Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human $CD34^-$ cells transplanted into conditioned NOD/SCID recipients. Blood 99:1585-1593   DOI   ScienceOn
17 Dunbar CE (1996): Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease. Annu Rev Med 47:11-20   DOI   ScienceOn
18 Burger JA, Spoo A, Dwenger A, Burger M, Behringer D (2003): CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human $CD34^+$ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis). Br J Haematol 122:579-89   DOI   ScienceOn
19 Yahata T, Ando K, Sato T, Miyatake H, Nakamura Y, Muguruma Y, Kato S, Hotta T (2003): Ahighly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow Blood 15:2905-2913
20 Cornetta K, Fan Y (1997): Retroviral gene therapy in hematopoietic diseases. J Clin Apheresis 12:187-193   DOI   ScienceOn
21 Wagers AJ, Allsopp RC, Weissman IL (2002): Changes in integrin expression are associated with altered homing properties of $Lin^{-/low}Thy1.1^{low}Sca-1^-c-Kit^-$-hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol 30:176-185   DOI   ScienceOn
22 Kaneko S, Onodera M, Fujiki Y, Nagasawa T, Nakauchi H (2001): Simplified retroviral vector GCsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in NOD/SCID Mice. Human gene thrapy 12:35-44   DOI   ScienceOn
23 Nelson DM, Metzger ME, Donahue RE, Morgan RA (1997): In vivo retrovirus mediated gene transfer into multiple hematopoietic lineages in rabbits without preconditioning. Hum Gene Therapy 8:747-754   DOI   ScienceOn
24 Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviere I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Glorioso J (2003): American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther 8:180-187   DOI   ScienceOn
25 Ballas CB, Zielske SP, Gerson, SL (2002): Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 38:20-28
26 Abonour R (2000): Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long term repopulating hematopoietic stem cells. Nat Med 6:652-658.10   DOI   ScienceOn